N/A N=56 Abdominal Binder to Reduce Pain and Seroma Formation
Ventral Hernias
Primary: Visual Analog Scale of Pain Activity — 50; 70 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=32 Fibrin Glue in Inguinal Lymphadenectomy
Seroma
Primary: Number of Participants With Seroma Formation — 2; 8 participants — p=0.022
N/A N=50 Influence of Fibrin Glue on Seroma Formation After Modified Radical Mastectomy
Breast Cancer
Primary: Seroma Formation — 770.48; 1089.51 ml
N/A N=68 Seroma Formation After Modified Radical Mastectomy With Flap Fixation Technique in Breast Cancer Patients
Breast-cancer
Primary: Seroma Formation — 54.27; 59.56; 102.21; 117.94 ml — p=<0.005
N/A N=72 Preventing Seroma Formation After Stripping Saphenous Vein in Coronary Bypass
Coronary Bypass Graft Stenosis of Autologous Vein
Primary: Early Complications of Vascular Zone — 1; 4; 15; 5 participants — p=0.05
N/A N=80 A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection
Lymph Node Dissection · Lymphoedema · Lymphocoele
Primary: Postoperative Draining Time — 31; 32 days
N/A N=46 Prevention of Seroma Formation and Wound Complications Using NPWT Devices
Seroma · Wound Dehiscence · Wound Infection
Primary: Post-operative Seroma Formation — 16.9; 10.1 cm^3
N/A N=60 Single Versus Double Drains After Mastectomy
Breast Cancer · Mastectomy
Primary: Patient Comfort Scale — 3; 3 units on a scale — p=0.490
Phase 4 N=74 Post-Operative Drainage Following Lymph Node Dissection
Malignant Melanoma · Carcinoma, Squamous Cell
Primary: Post-operative Wound Drainage. — 892.5; 762.5; 565; 590 ml — p=0.704
N/A N=34 SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery
Subjects Requiring Revision Breast Augmentation Surgery
Primary: Reoperation Rate (Per Implanted Breast) for the Presenting Condition at 12 Months. — 0; 0 Implanted breasts
N/A N=94 The Use of a High-frequency Ultrasonic Knife in Breast Cancer Surgery
Breast Cancer
Primary: Drainage Volume — 182.6; 525.2 milliliters — p=<0.05
N/A N=233 Use of Tachosil® for Lymph Sealing During Surgery
Lymph Node Resection
Primary: Percentage of Participants With Post-Operative Seroma Formation Over Time as Determined at Hospital Discharge — 2.63 percentage of participants
N/A N=13 Circumferential Periareolar Mastopexy Using SERI Surgical Scaffold
Mastopexy
Primary: Number of Participants With Areolar Dilation of up to 6mm at 12 Months — 13 Participants
N/A N=1 Prospective Evaluation of a Surgical Solution for Breast Cancer-Associated Lymphedema
Lymphedema · Edema
Primary: Change in Limb Volume — -15; -202 mL
N/A N=120 Prevention of Lymphoceles After Robotic PLND
Lymphoceles · Prostate Cancer
Primary: Incidence of Lymphoceles — 10; 12; 104; 102 participants — p=0.412
Phase 2 N=104 Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction
Nonmalignant Breast Conditions · Breast Cancer
Primary: Number of Subjects With Drain Bulb Fluid Bacterial Colonization at Approximately 1 Week — 10; 21 participants — p=0.02
N/A N=40 Regenerative Collagen Scaffold for Breast Volume Restoration After Breast Cancer Excision
Breast-Conserving Surgery
Primary: Volume Restoration — 33 Participants
N/A N=112 Fibrin Melanoma Axillary Node Study in Patients With Melanoma
Melanoma
Primary: Drain Duration — 23; 21 days
N/A N=399 Pancreas Resection With and Without Drains
Pancreas Tumor · Pancreatitis
Primary: 60-day ≥ Grade II Complication Rate — 72; 76 Participants — p=0.804